Previous Article | Next Article ![]()
Journal of Bacteriology, March 2003, p. 1958-1966, Vol. 185, No. 6
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.6.1958-1966.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
University of British Columbia Centre for Disease Control,1 Genome Sequence Centre, British Columbia Cancer Agency,3 The Prostate Centre at Vancouver General Hospital, Vancouver, British Columbia, Canada,4 The Institute for Genomic Research, Rockville, Maryland2
Received 10 September 2002/ Accepted 30 December 2002
|
|
|---|
|
|
|---|
|
|
|---|
Phylogenetic comparison of chlamydia GroELs. The protein sets of 75 completed bacterial genomes (http://www.tigr.org/CMR2/) were searched against chlamydial GroEL1, GroEL2, and GroEL3 by using the BLASTP (1) program. All proteins that matched the Chlamydia GroELs with a minimum threshold P value of 10-5 were aligned by using CLUSTALW (37). Protein distances were calculated by using a maximum-likelihood method (PROTDIST in the PHYLIP 3.6 package, University of Washington, Seattle) and plotted as an unrooted tree by using a neighbor-joining algorithm.
Sequence comparison and analysis. A database containing both nucleotide and amino acid sequences of all three groEL homologs of serovar D and biovar mouse pneumonitis (MoPn) of C. trachomatis, C. pneumoniae strain AR39, and the groEL gene of E. coli was collected from The Institute of Genomic Research database. Sequences were aligned by using the CLUSTALW program (37).
3-D structural predictions of C. trachomatis GroELs. (i) Threading. The threading approach uses pair potentials to score for the propensity of two amino acid residues to occur at a specified distance. The methodology relies on the assumption that different proteins fold into a limited number of shapes (estimated to be ca. 4,000). The strategy is to identify the folding pattern of the test protein sequence by fitting it onto a library of known structures by using pseudoenergy as a measure of fit (5, 14, 17, 18, 28, 29, 33, 36). The library of folds is ranked in ascending order of total energy, with the lowest energy fold being taken as the most probable match. The approach is sufficient to identify proteins that share common folds in the "twilight zone" (<25%) of sequence identity in which sequence-based approaches normally fail (29, 33). The amino acid sequences of C. trachomatis serovar D GroEL1 to GroEL3 were analyzed by using the THREADER2 package (18), and a score representing a statistical Z score of threading pseudoenergy was obtained for each of the fold matches from the library of known protein structures. The Z score reflects the "goodness" of threading of a given sequence into the corresponding model fold: a Z-score value of <2.0 means that the analyzed sequence does not correspond to known protein folds in the library; scores between 2.0 and 3.5 are considered possibly significant and may correctly predict fold identification; scores of >3.5 are very significant and are likely to represent correct fold prediction.
(ii) Homology modeling. The best fit of the threading results was used as a template for homology modeling. Homology modeling was carried out with MOE (for Molecular Operation Environment package, version 2001.01; Chemical Computing Group, Inc., Montreal, Quebec, Canada). Three dimensional structures for each of the C. trachomatis serovar D GroEL1 to GroEL3 proteins were derived as a Cartesian average of the 10 best intermediate models build by MOE.
Molecular cloning, expression, and purification of recombinant GroEL1, GroEL2, and GroEL3. groEL1, groEL2, and groEL3 DNA fragments were generated by PCR by using genomic DNA isolated from D serovar of C. trachomatis. In order to subclone the PCR product as KpnI fragment into pET30b(+) vector (Novagen), forward and reverse primers used for amplification were designed as shown in Table 1. PCRs were carried out with Pfu DNA polymerase (Stratagene). The reaction mixture contained 2 mM MgSO4, 200 µM concentrations of deoxynucleoside triphosphates, 2.5 U of Pfu DNA polymerase enzyme, and 25 pmol of each oligonucleotide primer in a total volume of 50 µl. The PCR cycling conditions were as follows: one cycle of 95°C for 2 min and 35 cycles of 94°C for 15 s, 58°C for 30 s, and 72°C for 2 min. This step was followed by strand elongation for 10 min at 72°C. The PCR product was purified with the QIAquick PCR purification kit (Qiagen), and the purified DNA fragment was cloned into pET30b(+) after restriction enzyme digestion by standard molecular biology techniques. The sequence of the subcloned groEL1, groEL2, and groEL3 genes were confirmed by sequencing with dye-labeled terminators by using the ABI PRISM kit (PE Biosystems). Plasmids containing the groEL1, groEL2, and groEL3 genes were transformed into the E. coli BL21(DE3) or BL21 Codonplus(DE3)RIL (Strategene), where GroEL1, GroEL2, and GroEL3 expression was carried out by inducing the lac promoter for expression of T7 RNA polymerase with IPTG (isopropyl-ß-D-thiogalactopyranoside). The expressed GroEL1, GroEL2, and GroEL3 proteins with N-terminal His tags were purified by nickel column chromatography by using the His Bind purification system (Qiagen).
|
View this table: [in a new window] |
TABLE 1. Primer sequencesa
|
Quantification of gene expression after heat shock by using a DNA microarray. (i) Primer design and PCR. PCR primers were designed to amplify the full-length open reading frame of 96 selected genes of C. trachomatis serovar D by using a computer algorithm written in our laboratory. The program adjusts the length of the primers to achieve a specified melting temperature. All N-terminal primers contained an "adaptamer" sequence with a KpnI restriction site and the C-terminal primers with a NotI site to facilitate directional cloning in later stages for functional analysis. The PCR amplification was the same as described above except that the final PCR products were ethanol precipitated and air dried.
(ii) Array procedure. DNA was dissolved in 3x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and divided into aliquots in a 384-well plate. Microarrays were fabricated on CMT-GAPS-coated microscope slides (Corning) with MicroGrid Microarrayer (BioRobotics, Cambridge, United Kingdom).
(ii) Probe preparation. Total RNA was extracted by using Trizol (Life Technologies) and treated with RNase-free DNase (Roche). Heat shock samples were subjected to a 10-min heat pulse to 45°C prior to RNA isolation. A total of 20 µg of RNA was labeled with cyanine 3 (Cy3)-dUTP or Cy5-dUTP by using Superscript II (Life Technologies) with randon hexamers (Roche).
(iii) Hybridization. Cy3- and Cy5-labeled cDNA were combined with DIG Easy Hyb solution (Roche), yeast tRNA (Life Technologies), and calf thymus DNA in a final volume of 30 µl and then hybridized to a microarray at 37°C for 18 h. Slides were then washed in 1x SSC with 0.1% sodium dodecyl sulfate (SDS) at 50°C and dried.
(iv) Analysis and quantification. Arrays were scanned on a Virtek Chipreader version 2.0 (Virtek Vision Corp., Waterloo, Ontario, Canada) and the Cy3 and Cy5 images were combined for quantification by using Imagine software (version 4.0; BioDiscovery, Inc., Los Angeles, Calif.). The quantified data for each spot were analyzed by using GeneSpring software (version 4.1; SiliconGenetics, San Carlos, Calif.). After background subtraction, the data were normalized by using a global normalization technique, and the signal intensities were calculated as the fold change of expression values. This experiment was performed twice with similar results.
Preparation of antisera against recombinant GroELs. Antisera to GroEL1, GroEL2, and GroEL3 were raised in BALB/c mice (Charles River Canada) by intraperitoneal injection of the recombinant proteins (100 µg of protein in incomplete Freund adjuvant), followed by two booster injections at 2-week intervals. Sera were collected and pooled 4 weeks after the final boost.
Western blotting. Samples for Western analysis were prepared by boiling purified serovar D C. trachomatis elementary bodies for 5 min in the protein sample buffer. The samples were subjected to SDS-7.5% polyacrylamide gel electrophoresis according to the method of Laemmli (22). The gels were blotted onto nitrocellulose membranes (Bio-Rad) at 70 V for 1 h in blotting buffer acccording to the method of Maniatis et al. (23). The filters were blocked overnight with Tris-buffered saline containing 3% bovine serum albumin at 4°C prior to incubation with polyclonal anti-GroEL antibodies and peroxidase-conjugated sheep anti mouse immunoglobulin G secondary antibodies. The blots were processed for color detection by using the substrate BCIP (5-bromo-4-chloro-3-indolylphosphate)-nitroblue tetrazolium.
E. coli complementation.
groEL1, groEL2, and groEL3 DNA fragments were generated by PCR with genomic DNA isolated from C. trachomatis serovar D and cloned into pBAD24 (16) as a KpnI fragment downstream of an arabinose-inducible promoter to yield the constructs pBADgroEL1, pBADgroEL2, and pBADgroEL3. The groES gene was cloned into pKPK as EcoRI/XhoI fragment downstream of IPTG-inducible lacUV5 promoter to yield pKPKgroES. pKPK was derived from pBT (Stratagene) by deleting the phage
cI gene (as a NotI/PshAI fragment), followed by filling in and ligation. The primers used for these amplifications are listed in Table 1. These plasmid constructs were transformed into E. coli NL441 (25), and transformants were grown at 37°C overnight in Luria broth with ampicillin (100 µg ml-1) and/or chloramphenicol (50 µg ml-1). Cultures were streaked onto two sets of plates containing an appropriate combination of antibiotics and inducers (ampicillin at 100 µg ml-1, chloramphenicol at 50 µg ml-1, and IPTG at 50 µM or as indicated) and various amounts of arabinose as indicated. One set of plates was incubated at 37°C, and the other was incubated at 42°C. Scoring for growth was done after an overnight incubation.
|
|
|---|
![]() View larger version (22K): [in a new window] |
FIG. 1. Phylogenetic relationships of chlamydial GroELs. The figure shows an unrooted tree of GroEL homologs in 75 completed genomes (see Materials and Methods for details regarding how the tree was constructed). Branches consisting of GroEL1, GroEL2, and GroEL3 cluster from six chlamydial genomes (C. trachomatis serovar D and biovar MoPn; C. pneumoniae strains AR39, CWL029, and J138; and C. psittaci) are indicated by shaded boxes. Bacterial genera at key branch points are also included.
|
|
View this table: [in a new window] |
TABLE 2. Percent identity of amino acid sequences of GroEL1, GroEL2, and GroEL3a
|
|
View this table: [in a new window] |
TABLE 3. Identity among multiple copies of GroEL in different bacteria
|
|
View this table: [in a new window] |
TABLE 4. Alignment of functional regions of E. coli GroEL sequence with those of chlamydial GroEL homologsa
|
Homology modeling of C. trachomatis serovar D GroEL1, GroEL2, and GroEL3 gave the predicted structures shown in Fig. 2A, B, and C, respectively. The estimated 3-D structures of GroEL1 to GroEL3 are very similar, except for the irregular N and C termini. Structural superposition of the predicted structures of C. trachomatis serovar D GroEL1 to GroEL3 proteins yielded the corresponding RMSD (i.e., the root mean square deviation of the atomic coordinates) value of only 0.9 Å (Fig. 2D).
![]() View larger version (43K): [in a new window] |
FIG. 2. Predicted 3-D structures of C. trachomatis serovar D GroEL1 (A), GroEL2 (B), and GroEL3 (C) (see Materials and Methods for details of how the 3-D prediction was done through homology modeling) and the structural superposition of the three predicted structures for GroEL1, GroEL2, and GroEL3 (D) (represented by green, blue, and yellow, respectively).
|
![]() View larger version (42K): [in a new window] |
FIG. 3. (A) The top panel shows control PCR amplification of groEL1, groEL2, and groEL3 with serovar D DNA as the template as a measure to compare primer efficiency. The bottom panel shows an RT-PCR analysis of total RNA from HeLa cells infected with C. trachomatis serovar D isolated at 12 h after infection. (B) The top panel shows a Western blot analysis of C. trachomatis serovar D GroEL1, GroEL2, and GroEL3. Boiled samples of purified serovar D C. trachomatis elementary bodies were subjected to SDS-7.5% polyacrylamide gel electrophoresis, and the blotted nitrocellulose membranes were incubated with polyclonal anti-GroEL1 (first lane), anti-GroEL2 (middle lane), or anti-GroEL3 (third lane) antibodies, followed by incubation with alkaline phosphatase-conjugated secondary antibodies and color detection. In the bottom panel is shown a quantification of GroEL1, GroEL2, and GroEL3 by using the procedure described above except that 1-, 10-, and 100-ng portions of recombinant proteins were loaded per lane.
|
![]() View larger version (13K): [in a new window] |
FIG. 4. Quantification of C. trachomatis serovar D groEL1, groEL2, and groEL3 expression after heat shock by using microarray. (groES and dnaK genes were included for comparison purposes). Heat-shocked and non-heat-shocked RNA samples were reverse transcribed, labeled with Cy3 or Cy5, and hybridized to the microarray. The fluorescence intensity was measured for each spot and then normalized to the average fluorescence intensity for the entire microarray. Data analysis was performed with the GeneSpring software (see Materials and Methods for more details).
|
(iv) Expression of GroEL1, GroEL2, and GroEL3 in C. trachomatis serovar D. Western blot analysis with antichlamydial GroEL polyclonal antibodies revealed positive bands for all three proteins in an elementary body lysate of C. trachomatis serovar D. All three GroELs were similar in size (ca. 60 kDa), and GroEL1 was more abundant than the other two GroELs, a finding consistent with the mRNA expression levels (Fig. 3B).
Complementation of an E. coli groEL mutant. To examine whether chlamydial groEL genes are functional, complementation tests were performed with each of the chlamydial groEL genes alone or with each of the chlamydial groEL genes and groES expressed from two different plasmids in the E. coli groEL mutant strain NL441 (25). NL441 is a temperature-sensitive groEL mutant strain that can grow up to 37°C but not at 42°C. The results are summarized in Table 5 and Fig. 5. The E. coli groEL mutant NL441 regained viability at 42°C only with the expression of C. trachomatis groEL1 and groES. The expression of groEL1 alone did not complement the defective E. coli groEL. NL441 transformed with plasmids carrying C. trachomatis groEL2 or groEL3 alone or together with C. trachomatis groES did not regain viability.
|
View this table: [in a new window] |
TABLE 5. Summary of results from the complementation experiments with E. coli groEL mutant strain NL441
|
![]() View larger version (36K): [in a new window] |
FIG. 5. Complementation of a temperature-sensitive mutant of E. coli groEL by C. trachomatis groEL1 and groES. Two independent transformants of NL441 strains containing the plasmid pairs indicated were streaked onto Luria-Bertani agar plates supplemented with ampicillin (100 µg/ml), chloramphenicol (50 µg/ml), and arabinose (as indicated) and then incubated at the temperatures indicated for 18 h.
|
|
|
|---|
As a general guideline, proteins with more than 30% sequence identity are usually similar in structure and function (3). On the other hand, a threshold of 25% identical residues has been used to define a "twilight zone" of sequence similarity, wherein the structural and functional homology between proteins is no longer certain (30). The chlamydial GroEL1, with 60% amino acid identity to E. coli chaperonin GroEL, is clearly a member of the GroEL family. However, chlamydial GroEL2 and GroEL3 fall near the twilight zone threshold value, and therefore speculation on their structural and functional identity based on sequence information alone is uncertain. However, the results of sequence analysis (Table 4) of conserved active-site amino acid residues (with reference to the E. coli GroEL), as well as protein modeling (Fig. 2), reliably group GroEL2 and GroEL3 proteins into the GroEL family.
Phylogenetic analyses of the chlamydial GroEL proteins indicate that GroEL1 may have arisen from a different lineage than did GroEL2 and GroEL3 (Fig. 1). The assignment of GroELs to different branches may be an artifact of phylogenetic reconstruction caused by the large evolutionary distance between chlamydiae and other bacteria and also to the small number of closely related genomes that have been sequenced to date. There are several possible explanations for the divergence among GroELs that may have a significant bearing on the understanding of the nature and function of these proteins. There may have been a period of rapid sequence evolution of GroEL2 and GroEL3 after duplication of the GroELs in a chlamydia-like ancestor; perhaps this change was related to adaptation for distinct cellular functions in a particular niche. Possibly when chlamydia established a niche as an obligate intracellular pathogen, with little opportunity for horizontal gene transfer, additional chaperonin activity was required to compensate for the acquisition of mildly deleterious mutations (10, 27). Since the origin of the Chlamydiaceae, the rates of change appear to have stabilized since each protein is equidistant from the other two. Alternative suggestions are that GroEL2 and GroEL3 may represent an ancestral lineage deleted from most other bacteria (but possibly conserved in Mycoplasma spp.) or that they were acquired by the chlamydiae through horizontal gene transfer in the remote past. We cannot discriminate among these possibilities.
In support of the phylogenetic analysis, groEL1 also differed from groEL2 and groEL3 in response to heat shock. Only the expression of groEL1and not groEL2 or groEL3increased when C. trachomatis serovar D was exposed to elevated temperature (Fig. 4). Although the expression of groEL1, groEL2, and groEL3 is constitutive throughout the developmental cycle of C. trachomatis, the level of groEL1 expression was highest (Fig. 3A). This finding was supported by a Western blot analysis (Fig. 3B) in which GroEL1 was found to be substantially more abundant than GroEL2 and GroEL3. Gene expression and protein abundances in bacteria can be regulated by different factors such as promoter strength, transcription factors, mRNA stability, and codon usage. We analyzed the codon usage for GroEL1, GroEL2, and GroEL3 in chlamydia, and our analysis revealed many rare codons in GroEL2, suggesting that the GroELs may be in part translationally regulated. This difference is consistent with the studies of Karlin and Mrazek (20), who carried out a statistical analysis of the expression of many bacterial proteins, including chlamydial GroEL1, GroEL2, and GroEL3. On the basis of codon usage, GroEL1, but not GroEL2 and GroEL3 was predicted to be a highly expressed gene. We also analyzed the potential promoter regions of groEL1, groEL2, and groEL3 in C. trachomatis serovar D, and only the groE operon (groES and groEL1) was found to contain the CIRCE (controlling inverted repeat of chaperone expression), as well as the putative
66 promoter element, as described for C. trachomatis MoPn strain (34). These data suggest that GroEL2 and GroEL3 are likely to have different regulatory mechanisms than does GroEL1.
Complementation of an E. coli groEL mutant by C. trachomatis groEL1 and groES genes together, but not with groEL1 alone, indicates that E. coli groES and chlamydial groEL are not functionally compatible. A similar phenomenon was also reported for Vibrio cholerae (26). In contrast, C. trachomatis groEL2 and groEL3, together with groES, were not able to complement the E. coli groEL mutant. Thus, even though GroEL2 and GroEL3 are expressed as proteins in chlamydiae and therefore are not pseudogenes, their physiologic role remains unclear.
In conclusion, we determined the grouping of the three chlamydial groEL genes within the groEL family based on sequence and structural properties. Transcriptional and translational expression analyses showed that all three genes are expressed in chlamydia and that they are not pseudogenes. Phylogenetic analysis, heat shock, and complementation assays indicated that groEL2 and groEL3 may have functions distinct from groEL1 and are differentially regulated. The low sequence similarity among groEL1, groEL2, and groEL3 compared to the level of identity reported for bacterial groELs in general also supports this speculation (Table 3). If chlamydial GroEL proteins play distinct roles in the accurate expression of information encoded in the genome, it will be of interest to determine whether each chaperonin plays a different role in the development cycle and in disease pathogenesis. Furthermore, it will be of interest to determine whether the chlamydial GroELs form homo- or heteropolymeric structures with variable stoichiometries in these processes.
This work was supported by a grant from The Canadian Institutes of Health Research. K.P.K. was supported by a fellowship from The Michael Smith Foundation for Health Research.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»